Join ASCO in Welcoming Dr John Cox As Editor-in-Chief

Por Schilsky, Richard L.
Publicado em 2008

Publicly Funded Clinical Trials and the Future of Cancer Care

Por Schilsky, Richard L.
Publicado em 2013

Highlights from the 2013 WIN Symposium: personalised cancer therapy from innovation to implementation

Por Schilsky, Richard L
Publicado em 2013

Highlights from the 2015 WIN Symposium: novel targets, innovative agents, and advanced technologies—a WINning strategy?

Por Schilsky, Richard L
Publicado no Ecancermedicalscience (2015)

Collaboration Between Cooperative Groups and Industry

Por Bressler, Linda R., Schilsky, Richard L.
Publicado em 2008

Clinical Trials in the Era of Personalized Oncology

Por Maitland, Michael L., Schilsky, Richard L.
Publicado em 2011

Data Submission Standards and Evidence Requirements

Por Abrams, Jeffrey, Erwin, Robert, Fyfe, Gwen, Schilsky, Richard L.
Publicado em 2010

Tomorrow’s Cancer Treatments Today: The First 50 Years of the Cancer and Leukemia Group B

Por Green, Mark R., George, Stephen L., Schilsky, Richard L.
Publicado em 2008

Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward

Por Menter, David G., Schilsky, Richard L., DuBois, Raymond N.
Publicado no Clin Cancer Res (2010)

Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer

Por Schilsky, Richard L., Allen, Jeff, Benner, Joshua, Sigal, Ellen, McClellan, Mark
Publicado em 2010

Development and Use of Integral Assays in Clinical Trials

Por Schilsky, Richard L., Doroshow, James H., LeBlanc, Michael, Conley, Barbara A.
Publicado em 2012

Opportunities for translational epidemiology: The important role of observational studies to advance precision oncology

Por Marrone, Michael, Schilsky, Richard L., Liu, Geoff, Khoury, Muin J., Freedman, Andrew N
Publicado no Cancer Epidemiol Biomarkers Prev (2015)

Synthesis, Retention, and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer Cells

Por Jolivet, Jacques, Schilsky, Richard L., Bailey, Brenda D., Drake, James C., Chabner, Bruce A.
Publicado em 1982

Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion

Por Fleming, Gini F, Schumm, Philip, Friberg, Greg, Ratain, Mark J, Njiaju, Uchenna O, Schilsky, Richard L
Publicado no BMC Cancer (2015)

Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists

Por Conti, Rena M., Bernstein, Arielle C., Villaflor, Victoria M., Schilsky, Richard L., Rosenthal, Meredith B., Bach, Peter B.
Publicado em 2013

The Translational Research Working Group Developmental Pathway for Anticancer Agents (Drugs or Biologics)

Por Schilsky, Richard L., Gordon, Gary, Gilmer, Tona M., Courtneidge, Sara A., Matrisian, Lynn M., Grad, Oren, Nelson, William G.
Publicado em 2008

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

Por Schwaederle, Maria, Zhao, Melissa, Lee, J. Jack, Eggermont, Alexander M., Schilsky, Richard L., Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Publicado no J Clin Oncol (2015)

Measuring Clinically Significant Chemotherapy-Related Toxicities Using Medicare Claims From Cancer and Leukemia Group B (CALGB) Trial Participants

Por Lamont, Elizabeth B., Herndon, James E., Weeks, Jane C., Henderson, I. Craig, Lilenbaum, Rogerio, Schilsky, Richard L., Christakis, Nicholas A.
Publicado em 2008

Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344)

Por Lamont, Elizabeth B., Herndon, James E., Weeks, Jane C., Henderson, I. Craig, Earle, Craig C., Schilsky, Richard L., Christakis, Nicholas A.
Publicado em 2006

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval

Por Fontes Jardim, Denis L., Schwaederle, Maria, Wei, Caimiao, Lee, J. Jack, Hong, David S., Eggermont, Alexander M., Schilsky, Richard L., Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Publicado no J Natl Cancer Inst (2015)